Hutch News

Stories tagged 'hiv vaccine'

New library of HIV mutants could inform vaccine design

Laboratory manipulation of the AIDS-causing virus reveals evolutionary ‘dead-ends’

Jan. 12, 2017 | By Rachel Tompa / Fred Hutch News Service

Fred Hutch researchers have created a library containing millions of mutant HIV viruses. Some of these mutants are very good at infecting human cells, no different from their “natural” viral ancestor. Some of them are worse. Together, they can teach researchers something important about HIV in humans.

View story >


'We've become full partners'

An HIV laboratory in South Africa advances scientific understanding, and more

Jan. 6, 2017 | By Mary Engel / Fred Hutch News Service

Fred Hutch immunologist Dr. Erica Andersen-Nissen moved to Cape Town, South Africa, in 2013 to set up a state-of-the-art HIV laboratory to anchor two groundbreaking vaccine clinical trials. This is the story of building that lab, from the people up.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

Dec. 1, 2016

Good News: Dr. Julie Overbaugh recognized for lifetime of mentorship; GivingTuesday fuels $75K in donations to Fred Hutch.

View story >


On World AIDS Day, renewed hope for an HIV vaccine

Clinical trial taking place in South Africa could 'dramatically alter the course of the pandemic’

Dec. 1, 2016 | By Mary Engel / Fred Hutch News Service

World’s AIDS Day 2016 brings especially hopeful news: A large-scale clinical trial has opened in South Africa to test an experimental HIV vaccine regimen that could lead to the first licensed vaccine against the virus that causes AIDS.

View story >


Quest for an HIV vaccine

Community trust is key as researchers start a new trial across 15 sites in South Africa

Nov. 29, 2016 | By Mary Engel / Fred Hutch News Service

Dr. Linda-Gail Bekker, deputy director of the Desmond Tutu HIV Centre at the University of Cape Town and a member of the Fred Hutch-based HIV Vaccine Trials Network, works closely with the communities most affected by HIV to end the epidemic. She is co-chairing a just-launched clinical trial in South Africa that could lead to the first licensed HIV vaccine.

View story >


Empowering ‘millions of women’ against HIV

AMP study in sub-Saharan Africa tests an antibody infusion that could put protection in women’s hands

Oct. 21, 2016 | By Mary Engel / Fred Hutch News Service

The AMP study in sub-Saharan Africa will test whether an antibody infusion protects women against HIV. If it does, the finding will have particular significance for an epidemic that hits women on that continent especially hard and for which they have few prevention options.

View story >



GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.